Pro Medicus Limited (PME:ASX)

Last update - 15 August 2023 By James Woods

A long-term holding within the value component of the ASX Growth portfolio, Pro Medicus (PME) this morning reported financial results for the 2023 financial year which exceeded estimates.

We are glad you are enjoying our content and we’d like to help you achieving your financial goals.

This content is only for Rivkin Report Members.

Start a free 14-day trial to access this article and:

  • 6 Model Portfolios for Income and Growth

  • In-Depth Stock Analysis: identify potential investment opportunities

  • Q&A sessions with our CIO, Shannon Rivkin

Be the first to know. Get the Morning Market Wrap each morning.